Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles.

Rees CA, Nasir M, Smolinska A, Lewis AE, Kane KR, Kossmann SE, Sezer O, Zucchi PC, Doi Y, Hirsch EB, Hill JE.

Sci Rep. 2018 Sep 5;8(1):13297. doi: 10.1038/s41598-018-31543-x.

2.

Angiotensin Converting Enzyme Gene Insertion/Deletion Variant and Familial Mediterranean Fever-related Amyloidosis.

Nursal AF, Turkmen E, Uzun Kaya S, Tekcan A, Sezer O, Celik SD, Yigit S.

Iran J Kidney Dis. 2018 May;12(3):150-155.

3.

Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.

Caers J, Paiva B, Zamagni E, Leleu X, Bladé J, Kristinsson SY, Touzeau C, Abildgaard N, Terpos E, Heusschen R, Ocio E, Delforge M, Sezer O, Beksac M, Ludwig H, Merlini G, Moreau P, Zweegman S, Engelhardt M, Rosiñol L.

J Hematol Oncol. 2018 Jan 16;11(1):10. doi: 10.1186/s13045-017-0549-1. Review.

4.

Acute dystonic reaction leading to lingual hematoma mimicking angioedema.

Sezer Ö, Aydin AA, Bilge S, Arslan F, Arslan H.

Indian J Pharmacol. 2017 Jul-Aug;49(4):325-327. doi: 10.4103/ijp.IJP_620_16.

5.

Humblebragging: A distinct-and ineffective-self-presentation strategy.

Sezer O, Gino F, Norton MI.

J Pers Soc Psychol. 2018 Jan;114(1):52-74. doi: 10.1037/pspi0000108. Epub 2017 Sep 18.

PMID:
28922000
6.

MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort.

Nursal AF, Kaya S, Sezer O, Karakus N, Yigit S.

J Clin Lab Anal. 2018 Feb;32(2). doi: 10.1002/jcla.22259. Epub 2017 May 22.

PMID:
28543752
7.

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Musto P, Anderson KC, Attal M, Richardson PG, Badros A, Hou J, Comenzo R, Du J, Durie BGM, San Miguel J, Einsele H, Chen WM, Garderet L, Pietrantuono G, Hillengass J, Kyle RA, Moreau P, Lahuerta JJ, Landgren O, Ludwig H, Larocca A, Mahindra A, Cavo M, Mazumder A, McCarthy PL, Nouel A, Rajkumar SV, Reiman A, Riva E, Sezer O, Terpos E, Turesson I, Usmani S, Weiss BM, Palumbo A; International Myeloma Working Group.

Ann Oncol. 2018 Apr 1;29(4):1074. doi: 10.1093/annonc/mdx160. No abstract available.

PMID:
28541409
8.

Fetal Nasal Bone Length as a Novel Marker for Prediction of Adverse Perinatal Outcomes in the First-Trimester of Pregnancy.

Canda MT, Demir N, Sezer O.

Balkan Med J. 2017 Apr 5;34(2):127-131. doi: 10.4274/balkanmedj.2016.2016.0133.

9.

Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.

Sezer O, Beksac M, Hajek R, Sucak G, Cagirgan S, Linkesch W, Meltem Akay O, Gülbas Z, Nahi H, Plesner T, Snowden JA, Timurağaoğlu A, Dechow T, Lang A, Tuğlular T, Drach J, Armbrecht G, Potamianou A, Couturier C, Olie RA, Feys C, Allietta N, Terpos E.

Br J Haematol. 2017 Jul;178(1):61-71. doi: 10.1111/bjh.14637. Epub 2017 Apr 6.

PMID:
28382618
10.

Cytopathologic differential diagnosis of low-grade urothelial carcinoma and reactive urothelial proliferation in bladder washings: a logistic regression analysis.

Cakir E, Kucuk U, Pala EE, Sezer O, Ekin RG, Cakmak O.

APMIS. 2017 May;125(5):431-436. doi: 10.1111/apm.12657. Epub 2017 Feb 22.

PMID:
28225151
11.

Genital region cleansing wipes: Effects on urine culture contamination.

Selek MB, Bektöre B, Sezer O, Kula Atik T, Baylan O, Özyurt M.

J Infect Dev Ctries. 2017 Jan 30;11(1):102-105. doi: 10.3855/jidc.8910.

12.

Can platelet count/spleen diameter ratio be used for cirrhotic children to predict esophageal varices?

Sezer OB, Çelik D, Tutar N, Özçay F.

World J Hepatol. 2016 Nov 28;8(33):1466-1470.

13.

Second primary malignancies in multiple myeloma: an overview and IMWG consensus.

Musto P, Anderson KC, Attal M, Richardson PG, Badros A, Hou J, Comenzo R, Du J, Durie BGM, San Miguel J, Einsele H, Chen WM, Garderet L, Pietrantuono G, Hillengass J, Kyle RA, Moreau P, Lahuerta JJ, Landgren O, Ludwig H, Larocca A, Mahindra A, Cavo M, Mazumder A, McCarthy PL, Nouel A, Rajkumar SV, Reiman A, Riva E, Sezer O, Terpos E, Turesson I, Usmani S, Weiss BM, Palumbo A; International Myeloma Working Group.

Ann Oncol. 2017 Feb 1;28(2):228-245. doi: 10.1093/annonc/mdw606. Review. Erratum in: Ann Oncol. 2017 May 24;:.

14.

Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.

Straka C, Liebisch P, Salwender H, Hennemann B, Metzner B, Knop S, Adler-Reichel S, Gerecke C, Wandt H, Bentz M, Bruemmendorf TH, Hentrich M, Pfreundschuh M, Wolf HH, Sezer O, Bargou R, Jung W, Trümper L, Hertenstein B, Heidemann E, Bernhard H, Lang N, Frickhofen N, Hebart H, Schmidmaier R, Sandermann A, Dechow T, Reichle A, Schnabel B, Schäfer-Eckart K, Langer C, Gramatzki M, Hinke A, Emmerich B, Einsele H.

Haematologica. 2016 Nov;101(11):1398-1406. Epub 2016 Aug 4.

15.

Anaphylactic reactions presenting with hypertension.

Solmazgul E, Kutlu A, Dogru S, Ozalper V, Cetindagli I, Sezer O, Salmanoglu M, Kilic E, Karabacak E, Ozturk S.

Springerplus. 2016 Aug 2;5(1):1223. doi: 10.1186/s40064-016-2913-y. eCollection 2016.

16.

A New Approach to the Prophylaxis of Cyclic Vomiting: Topiramate.

Sezer OB, Sezer T.

J Neurogastroenterol Motil. 2016 Oct 30;22(4):656-660. doi: 10.5056/jnm16035.

17.

The IL4-VNTR P1 Allele, IL4-VNTR P2P2 Genotype, and IL4-VNTR_IL6-174CG P2P1-GG Genotype Are Associated with an Increased Risk of Brucellosis.

Gunal O, Yigit S, Yalcın AD, Celik B, Barut S, Demir O, Ates O, Duygu F, Kaya S, Rustemoglu A, Sezer O.

Jpn J Infect Dis. 2017 Jan 24;70(1):61-64. doi: 10.7883/yoken.JJID.2015.550. Epub 2016 May 9.

18.

Low 25-hydroxyvitamin D level is not an independent risk factor for hepatosteatosis in obese children.

Sezer OB, Buluş D, Hızlı Ş, Andıran N, Yılmaz D, Ramadan SU.

J Pediatr Endocrinol Metab. 2016 Jul 1;29(7):783-8. doi: 10.1515/jpem-2015-0426.

PMID:
27089408
19.

Comparison of tuberculin skin test and quantiferon-TB gold in tube test for diagnosis of latent tuberculosis infection in health care workers: A cross sectional study.

Bozkanat E, Kaya H, Sezer O, Caliskan T, Kilic E, Ciftci F, Gumus S, Kartaloglu Z.

J Pak Med Assoc. 2016 Mar;66(3):270-4.

20.

Interleukin-1Ra rs2234663 and Interleukin-4 rs79071878 Polymorphisms in Familial Mediterranean Fever.

Nursal AF, Tekcan A, Kaya SU, Sezer O, Yigit S.

Gene. 2016 May 15;582(2):173-7. doi: 10.1016/j.gene.2016.02.008. Epub 2016 Feb 6.

PMID:
26861613
21.

Vicarious contagion decreases differentiation - and comes with costs.

Sezer O, Norton MI.

Behav Brain Sci. 2016 Jan;39:e162. doi: 10.1017/S0140525X15001508. Review.

PMID:
28355796
22.

Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group.

Laubach J, Garderet L, Mahindra A, Gahrton G, Caers J, Sezer O, Voorhees P, Leleu X, Johnsen HE, Streetly M, Jurczyszyn A, Ludwig H, Mellqvist UH, Chng WJ, Pilarski L, Einsele H, Hou J, Turesson I, Zamagni E, Chim CS, Mazumder A, Westin J, Lu J, Reiman T, Kristinsson S, Joshua D, Roussel M, O'Gorman P, Terpos E, McCarthy P, Dimopoulos M, Moreau P, Orlowski RZ, Miguel JS, Anderson KC, Palumbo A, Kumar S, Rajkumar V, Durie B, Richardson PG.

Leukemia. 2016 May;30(5):1005-17. doi: 10.1038/leu.2015.356. Epub 2015 Dec 29. Review.

PMID:
26710887
23.

Genes that Affect Brain Structure and Function Identified by Rare Variant Analyses of Mendelian Neurologic Disease.

Karaca E, Harel T, Pehlivan D, Jhangiani SN, Gambin T, Coban Akdemir Z, Gonzaga-Jauregui C, Erdin S, Bayram Y, Campbell IM, Hunter JV, Atik MM, Van Esch H, Yuan B, Wiszniewski W, Isikay S, Yesil G, Yuregir OO, Tug Bozdogan S, Aslan H, Aydin H, Tos T, Aksoy A, De Vivo DC, Jain P, Geckinli BB, Sezer O, Gul D, Durmaz B, Cogulu O, Ozkinay F, Topcu V, Candan S, Cebi AH, Ikbal M, Yilmaz Gulec E, Gezdirici A, Koparir E, Ekici F, Coskun S, Cicek S, Karaer K, Koparir A, Duz MB, Kirat E, Fenercioglu E, Ulucan H, Seven M, Guran T, Elcioglu N, Yildirim MS, Aktas D, Alikaşifoğlu M, Ture M, Yakut T, Overton JD, Yuksel A, Ozen M, Muzny DM, Adams DR, Boerwinkle E, Chung WK, Gibbs RA, Lupski JR.

Neuron. 2015 Nov 4;88(3):499-513. doi: 10.1016/j.neuron.2015.09.048.

24.

European Myeloma Network guidelines for the management of multiple myeloma-related complications.

Terpos E, Kleber M, Engelhardt M, Zweegman S, Gay F, Kastritis E, van de Donk NW, Bruno B, Sezer O, Broijl A, Bringhen S, Beksac M, Larocca A, Hajek R, Musto P, Johnsen HE, Morabito F, Ludwig H, Cavo M, Einsele H, Sonneveld P, Dimopoulos MA, Palumbo A; European Myeloma Network.

Haematologica. 2015 Oct;100(10):1254-66. doi: 10.3324/haematol.2014.117176.

25.

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma.

Giralt S, Garderet L, Durie B, Cook G, Gahrton G, Bruno B, Hari P, Lokhorst H, McCarthy P, Krishnan A, Sonneveld P, Goldschmidt H, Jagannath S, Barlogie B, Mateos M, Gimsing P, Sezer O, Mikhael J, Lu J, Dimopoulos M, Mazumder A, Palumbo A, Abonour R, Anderson K, Attal M, Blade J, Bird J, Cavo M, Comenzo R, de la Rubia J, Einsele H, Garcia-Sanz R, Hillengass J, Holstein S, Johnsen HE, Joshua D, Koehne G, Kumar S, Kyle R, Leleu X, Lonial S, Ludwig H, Nahi H, Nooka A, Orlowski R, Rajkumar V, Reiman A, Richardson P, Riva E, San Miguel J, Turreson I, Usmani S, Vesole D, Bensinger W, Qazilbash M, Efebera Y, Mohty M, Gasparreto C, Gajewski J, LeMaistre CF, Bredeson C, Moreau P, Pasquini M, Kroeger N, Stadtmauer E.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2039-2051. doi: 10.1016/j.bbmt.2015.09.016. Epub 2015 Sep 30.

26.

Significance of TNM staging, Demographic and Histologic Features in Predicting the Prognosis of Renal Cell Carcinoma.

Kucuk U, Pala EE, Sezer O, Cakir E, Bayol U, Divrik RT.

Acta Chir Belg. 2015 May-Jun;115(3):202-7.

PMID:
26158251
27.

Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder.

Kucuk U, Pala EE, Cakır E, Sezer O, Bayol U, Divrik RT, Cakmak O.

Cent European J Urol. 2015;68(1):30-6. doi: 10.5173/ceju.2015.01.465. Epub 2015 Mar 13.

28.

Approximation and compression with sparse orthonormal transforms.

Sezer OG, Guleryuz OG, Altunbasak Y.

IEEE Trans Image Process. 2015 Aug;24(8):2328-43. doi: 10.1109/TIP.2015.2414879. Epub 2015 Mar 23.

PMID:
25823033
29.

Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement.

Dimopoulos MA, Hillengass J, Usmani S, Zamagni E, Lentzsch S, Davies FE, Raje N, Sezer O, Zweegman S, Shah J, Badros A, Shimizu K, Moreau P, Chim CS, Lahuerta JJ, Hou J, Jurczyszyn A, Goldschmidt H, Sonneveld P, Palumbo A, Ludwig H, Cavo M, Barlogie B, Anderson K, Roodman GD, Rajkumar SV, Durie BG, Terpos E.

J Clin Oncol. 2015 Feb 20;33(6):657-64. doi: 10.1200/JCO.2014.57.9961. Epub 2015 Jan 20.

PMID:
25605835
30.

Is it necessary to re-evaluate diagnostic criteria for Wilson disease in children?

Sezer OB, Perk P, Hoşnut FÖ, Köse SK, Özcay F.

Turk J Gastroenterol. 2014 Dec;25(6):690-5. doi: 10.5152/tjg.2014.7787.

31.

Problems In Determining Her2 Status In Breast Carcinoma.

Pala EE, Bayol Ü, Özgüzer A, Küçük Ü, Akdeniz ÇY, Sezer Ö.

J Breast Health. 2015 Jan 1;11(1):10-16. doi: 10.5152/tjbh.2014.2103. eCollection 2015 Jan.

32.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF.

Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26. Review.

33.

Fibular aplasia, tibial campomelia, and oligosyndactyly: a further patient with a 2-year follow-up.

Sezer O, Gebesoglu I, Yuan B, Karaca E, Gokce E, Gunes S.

Clin Dysmorphol. 2014 Oct;23(4):121-6. doi: 10.1097/MCD.0000000000000051. No abstract available.

PMID:
25144151
34.

Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphoma.

Straka C, Salwender H, Schnabel B, Sandherr M, Wandt H, Hübel K, Scheid C, Metzner B, Hentrich M, Franke D, Weidenegger G, Freund M, Sezer O, Einsele H, Hinke A, Emmerich B.

Leuk Lymphoma. 2015 Feb;56(2):368-76. doi: 10.3109/10428194.2014.919631. Epub 2014 May 27.

PMID:
24794810
35.

The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.

van de Donk NW, Palumbo A, Johnsen HE, Engelhardt M, Gay F, Gregersen H, Hajek R, Kleber M, Ludwig H, Morgan G, Musto P, Plesner T, Sezer O, Terpos E, Waage A, Zweegman S, Einsele H, Sonneveld P, Lokhorst HM; European Myeloma Network.

Haematologica. 2014 Jun;99(6):984-96. doi: 10.3324/haematol.2013.100552. Epub 2014 Mar 21. Review.

36.

[Investigation of the presence of human metapneumovirus in patients with chronic obstructive pulmonary disease and asthma and its relationship with the attacks].

Ilvan A, Aslan G, Serin MS, Calıkoğlu M, Yılmaz FM, Tezcan S, Taş D, Ayrık C, Uygungül E, Sezer O, Emekdaş G.

Mikrobiyol Bul. 2013 Oct;47(4):636-49. Turkish.

37.

Phase Ib study of panobinostat and bortezomib in relapsed or relapsed and refractory multiple myeloma.

San-Miguel JF, Richardson PG, Günther A, Sezer O, Siegel D, Bladé J, LeBlanc R, Sutherland H, Sopala M, Mishra KK, Mu S, Bourquelot PM, Victoria Mateos M, Anderson KC.

J Clin Oncol. 2013 Oct 10;31(29):3696-703. doi: 10.1200/JCO.2012.46.7068. Epub 2013 Sep 9.

PMID:
24019544
38.

International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease.

Terpos E, Morgan G, Dimopoulos MA, Drake MT, Lentzsch S, Raje N, Sezer O, García-Sanz R, Shimizu K, Turesson I, Reiman T, Jurczyszyn A, Merlini G, Spencer A, Leleu X, Cavo M, Munshi N, Rajkumar SV, Durie BG, Roodman GD.

J Clin Oncol. 2013 Jun 20;31(18):2347-57. doi: 10.1200/JCO.2012.47.7901. Epub 2013 May 20.

39.

The proteasome inhibitor bortezomib stimulates osteoblastic differentiation of human osteoblast precursors via upregulation of vitamin D receptor signalling.

Kaiser MF, Heider U, Mieth M, Zang C, von Metzler I, Sezer O.

Eur J Haematol. 2013 Apr;90(4):263-72. doi: 10.1111/ejh.12069. Epub 2013 Feb 15.

PMID:
23311753
40.

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group.

Fernández de Larrea C, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH, Hajek R, San Miguel JF, Sezer O, Sonneveld P, Kumar SK, Mahindra A, Comenzo R, Palumbo A, Mazumber A, Anderson KC, Richardson PG, Badros AZ, Caers J, Cavo M, LeLeu X, Dimopoulos MA, Chim CS, Schots R, Noeul A, Fantl D, Mellqvist UH, Landgren O, Chanan-Khan A, Moreau P, Fonseca R, Merlini G, Lahuerta JJ, Bladé J, Orlowski RZ, Shah JJ; International Myeloma Working Group.

Leukemia. 2013 Apr;27(4):780-91. doi: 10.1038/leu.2012.336. Epub 2012 Nov 21. Review.

41.

Ferritin and bile acid levels during the intrauterine pre-treatment of gastroschisis by serial amnioexchange.

Demir N, Canda MT, Kuday S, Oztürk C, Sezer O, Danaoğlu N.

J Turk Ger Gynecol Assoc. 2013 Mar 1;14(1):53-5. doi: 10.5152/jtgga.2013.13. eCollection 2013.

43.

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.

Avet-Loiseau H, Durie BG, Cavo M, Attal M, Gutierrez N, Haessler J, Goldschmidt H, Hajek R, Lee JH, Sezer O, Barlogie B, Crowley J, Fonseca R, Testoni N, Ross F, Rajkumar SV, Sonneveld P, Lahuerta J, Moreau P, Morgan G; International Myeloma Working Group.

Leukemia. 2013 Mar;27(3):711-7. doi: 10.1038/leu.2012.282. Epub 2012 Oct 3.

44.

Infections in the time of war--no antibiotic but a vapour box.

Turhan V, Sezer O, Ozkuzugudenli B.

Scand J Infect Dis. 2012 Dec;44(12):1009. doi: 10.3109/00365548.2012.707332. Epub 2012 Sep 19. No abstract available.

PMID:
22992011
45.

Leptospirosis as a still unknown and underappreciated disease.

Turhan V, Sezer O.

Int J Prev Med. 2012 Aug;3(8):591-2. No abstract available.

46.
47.

Role of interleukin 16 in multiple myeloma.

Atanackovic D, Hildebrandt Y, Templin J, Cao Y, Keller C, Panse J, Meyer S, Reinhard H, Bartels K, Lajmi N, Sezer O, Zander AR, Marx AH, Uhlig R, Zustin J, Bokemeyer C, Kröger N.

J Natl Cancer Inst. 2012 Jul 3;104(13):1005-20. doi: 10.1093/jnci/djs257. Epub 2012 Jun 28.

PMID:
22745469
48.

Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients.

Kobold S, Luetkens T, Bartels BM, Cao Y, Hildebrandt Y, Sezer O, Reinhard H, Templin J, Bartels K, Lajmi N, Haag F, Bokemeyer C, Kröger N, Atanackovic D.

Clin Dev Immunol. 2012;2012:134081. doi: 10.1155/2012/134081. Epub 2012 Mar 12.

49.

[Tuberculosis incidence and primary drug resistance rates in young soldiers: data from 14 military hospitals in Turkey].

Taş D, Taşçı C, Demirer E, Sezer O, Okutan O, Kartaloğlu Z.

Mikrobiyol Bul. 2012 Jan;46(1):26-32. Turkish.

PMID:
22399168
50.

Prenatal diagnosis of a 22q11 deletion in a second-trimester fetus with conotruncal anomaly, absent thymus and meningomyelocele: Kousseff syndrome.

Canda MT, Demir N, Bal FU, Doganay L, Sezer O.

J Obstet Gynaecol Res. 2012 Apr;38(4):737-40. doi: 10.1111/j.1447-0756.2011.01770.x. Epub 2012 Mar 2.

PMID:
22380655

Supplemental Content

Support Center